New immunization technologies, 12 clinical studies, 248 scientific publications, 6 patents: these numbers summarize the results of 6 years of work within the European research…
New immunization technologies, 12 clinical studies, 248 scientific publications, 6 patents: these numbers summarize the results of 6 years of work within the European research…
The High Impact Project ADITEC, was launched in October 2011 to develop new vaccination strategies. The scope of the project, funded through the 7th Framework…
ADITEC’s Scientific and Socio-Economic Impact Report Thomson Reuters Impact Report Published The ADITEC Scientific and Socio-Economic Impact Report by Thomson Reuters, first presented at the…
We are pleased to inform you about the new training module “Advanced Course in Flow Cytometry Applied to Vaccinology” organised by University of Siena within…
Recognizing some of the most significant medical discoveries from around the world, The Gairdner Foundation has awarded Dr. Rino Rappuoli, Chief Scientist and Head External…
ADITEC is pleased to announce that the 2017 Albert B. Sabin Gold Medal award has been presented to Dr. Jan Holmgren for his pioneering contributions…
The next ADITEC Annual Meeting will be held in Siena (Italy), from the 18th till the 20th of September 2017.
The first report on comparative systems biology analysis of these four adjuvants was produced. The results of whole genome transcriptional analysis unrevealed common and unique…
Dear ADITEC Partner and Associates, We wish you and your families a Merry Christmas and a very Happy New Year. We take the opportunity to…